{"id":"W3011153961","doi":"10.1002/cpdd.789","title":"The Bioequivalence of Tafamidis 61‐mg Free Acid Capsules and Tafamidis Meglumine 4 × 20‐mg Capsules in Healthy Volunteers","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Pfizer","keywords":"Medicine; Bioequivalence; Dosing; Tolerability; Pharmacology; Crossover study; Pharmacokinetics; Internal medicine; Placebo; Adverse effect","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003495945,0.0009198753,0.001353391,0.0004362974,0.000360444,0.000624784,0.000470646,0.001527372,0.002022579],"category_scores_gemma":[0.003223661,0.0008031015,0.0008131546,0.0003106384,0.0009870257,0.000986559,0.0003686487,0.00110271,0.0007977958],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003227926,"about_ca_system_score_gemma":0.0005053749,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006700127,"about_ca_topic_score_gemma":0.0004990579,"domain_scores_codex":[0.9975211,0.001248065,0.0001771506,0.0005608899,0.000337512,0.000155243],"domain_scores_gemma":[0.9985681,0.0004638801,0.0003266275,0.000239735,0.0001682719,0.000233352],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7641966,0.02135146,0.00628663,0.0004332161,0.0007001832,0.0001700629,0.0008568504,0.0008198224,0.1678689,0.0003110323,0.0006678003,0.03633739],"study_design_scores_gemma":[0.0654442,0.8259242,0.06733806,0.00004614784,0.0009408527,0.0003586251,0.0002496328,0.00507088,0.03183652,0.0003281283,0.002348303,0.000114546],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976719,0.0005248436,0.0006811122,0.00003098511,0.0000745263,0.0004374823,0.0001815052,0.00002518894,0.0003723848],"genre_scores_gemma":[0.9966446,0.0003244568,0.001060001,0.0001351251,0.00009521582,0.000564826,0.0003061537,0.00001561518,0.0008539972],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003495945,"threshold_uncertainty_score":0.01848853,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03342460266546551,"score_gpt":0.3503987466890036,"score_spread":0.3169741440235381,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}